Vaxcyte executive exercises and sells 17,000 shares
Vaxcyte, Inc. executive Harpreet S. Dhaliwal, Chief Technical Ops Officer, reported an option exercise and related share sale.
Rhea-AI Filing Summary
Vaxcyte, Inc. executive Harpreet S. Dhaliwal, Chief Technical Ops Officer, reported an option exercise and related share sale. On August 5, 2026, he exercised stock options covering 17,000 shares of common stock at an exercise price of $24.79 per share from a fully vested option grant, and reported holding 28,000 stock options after the transaction.
The same day, he sold 17,000 common shares at a weighted-average price of $55.004 per share, with trade prices ranging from $55.00 to $55.255, under a Rule 10b5-1 trading plan adopted on April 6, 2026. His reported direct common stock position includes 780 shares acquired through the Employee Stock Purchase Plan on May 15, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 17,000 shares ($514K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Dhaliwal Harpreet S.
Role
Chief Technical Ops Officer
Sold
17,000 shs ($935K)
Approx. gross sale proceeds
$935K
Approx. exercise cost
$421K
Approx. pre-tax spread
$514K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F4 | 17,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 17,000 | $24.79 | $421K |
| Sale | Common Stock F2, F3 | 17,000 | $55.004 | $935K |
Holdings After Transaction:
Stock Option (right to buy) — 28,000 contracts (Direct);
Common Stock — 76,756 shares (Direct)
Footnotes (4)
- F1. Includes 780 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
- F2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026.
- F3. The price reported is a weighted-average price. The shares were sold at prices ranging from $55.00 to $55.255. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4. Stock Option is fully vested and exercisable.
Key Figures
Options exercised: 17,000 shares
Exercise price: $24.79 per share
Shares sold: 17,000 shares
+3 more
6 metrics
Options exercised
17,000 shares
Stock options converted into common stock on August 5, 2026
Exercise price
$24.79 per share
Strike price for the 17,000-share stock option exercised
Shares sold
17,000 shares
Common stock sold on August 5, 2026 following the option exercise
Weighted-average sale price
$55.004 per share
Sale of 17,000 shares; trades ranged from $55.00 to $55.255
Options remaining
28,000 shares
Stock options reported held after the 17,000-share exercise
ESPP shares
780 shares
Shares acquired under the Employee Stock Purchase Plan on May 15, 2026
Key Terms
Rule 10b5-1 trading plan, weighted-average price, Employee Stock Purchase Plan, Stock Option
4 terms
Rule 10b5-1 trading plan financial
"sales reported were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported is a weighted-average price. The shares were sold at prices"
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
Employee Stock Purchase Plan financial
"Includes 780 shares acquired under the Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Stock Option financial
"Stock Option is fully vested and exercisable."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Vaxcyte (PCVX) executive Harpreet S. Dhaliwal report?
Harpreet S. Dhaliwal reported exercising options for 17,000 Vaxcyte shares at $24.79 and selling 17,000 shares at a weighted-average $55.004 on August 5, 2026. The exercise reduced his option position and the sale occurred immediately after conversion.
What option holdings does Harpreet S. Dhaliwal report for Vaxcyte (PCVX)?
After exercising, Dhaliwal reported holding 28,000 stock options. The exercised option, covering 17,000 shares at $24.79, was fully vested and exercisable and carries an expiration date of March 2, 2032, according to the filing footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
